Videos

Céline
Wessa
UAntwerpen

Why don't antidepressants work for everyone?

As many as one in five Belgians struggle with depression at some point in their lives. Doctors then often opt for therapy and medication, including antidepressants. Yet 1/3rd of patients do not respond to those antidepressants. For them, anti-inflammatories may offer relief. Céline Wessa tells you how in this video.
Joyce
Bosmans
UAntwerpen

Alzheimer's puts you off balance

Alzheimer's not only affects memory, but also balance and orientation. "People with Alzheimer's move more slowly and unsafely, putting them at greater risk of falls and broken bones than their healthy peers," Joyce Bosmans explains. She advocates helping people with Alzheimer's to get balance training.
Leonore
Vander Donck
UAntwerpen

How vagina-friendly is your underwear?

Did you know that as many as 3 in 4 women suffer from a vaginal yeast infection at some point in their lives? But does the type of underwear they wear play a role in this? That's what Leonore Vander Donck (UAntwerpen) is looking into.
Tim
Boogaerts
UAntwerpen

The sewer as a mirror of society

Tim Boogaerts (UAntwerp) dives into sewers for his research. "Why would you do that?", we hear you thinking. Well, because sewage offers a wealth of information on the use of drugs, alcohol, and medicines in our society. Tim explains how that works.
Rani
Kronenberger
VUB

Fast and furious hearts: on a quest for a cure

One in 100 people suffer from a chronic heart condition. For example, their heart beats too fast even at rest, leaving these patients completely exhausted. Fortunately, surgery can help, but the procedure is risky and can lead to damage to the heart. To eliminate this risk, Rani Kronenberger (VUB) and her colleagues turn to 3D printing ...
Aarushi
Caro
KU Leuven
VUB

Ovarian cancer: treating ourselves with our cells!

Every 3 minutes, a woman dies of ovarian cancer somewhere in the world. "Ovarian cancer is very sneaky. Most of the patients respond positively to the therapies initially provided to them, but eventually, the cancer comes back and is much more aggressive. As a result one in two ovarian cancer patients die within 5 years after diagnosis." But what if we were able to treat ovarian cancer with a new therapy using our cells?
Kenza
Mostaqim
VUB

Getting ahead of cancer treatment's side effects

What if there might be a way to tackle the side effects of cancer treatments, such as fatigue, chronic pain and anxiety, even before the treatment begins? Kenza Mostaqim (VUB) introduces you to 'prehabilitation'.
Lara
De Deyn
UAntwerpen
VIB

Alzheimer's disease: from smoothie to fruit salad

Have you ever enjoyed a delicious smoothie? The way this tasty drink is made has similarities to how Alzheimer's disease research has been approached in the past decades. In this video, Lara De Deyn explains why she chooses a fruit salad approach in her research. A very nice metaphor to tell how Alzheimer's disease research is evolving.
Alvaro
Martin Hermosilla
VIB
VUB

Creating new proteins for a future without diseases

Why do people get cancer, arthritis, or Alzheimer's? Essentially because a protein key in our body does not fit in its respective lock. This is why Alvaro Martin is looking at removing defective keys and designing new protein keys. Keys that fit and can open the necessary locks, so that for example, our immune cells target and kill cancerous cells. "Protein design can be the key to unlocking a future without diseases."
Pauline
Bardet
FWO
VIB
VUB

We ignore some lung cancer cells. Is that smart?

Up to 25% of the cells present in lung cancer tumours are currently ignored. As such, we don't know what the role of these so-called B cells is. "It is crucial to figure that out because we cannot efficiently fight something we do not fully understand," says Pauline Bardet (VUB - VIB - FWO).

In her PhD, she wants to get to the bottom of those B cells and thus find out whether those cells are "good guys" or "bad guys".
Myrthe
Mampay
VUB

Stem cells in the battle against brain tumors

Once diagnosed with glioblastoma, a highly aggressive brain cancer, a patient has on average only 15 months to live. "This terrible statistic shows that we urgently need new treatment options," says Myrthe Mampay (VUB - FWO). In her research, she is looking for one such new treatment based on immunotherapy, in which she wants to use patient stem cells to make macrophages that attack the tumour.
Milos
Mihajlovic
VUB

What does the liver think of artificial feeding?

Artificial feeding, such as parenteral nutrition -food that is injected directly into the bloodstream- is crucial for critically ill patients. It keeps them alive, but unfortunately, it can cause significant liver damage in the long run. To prevent liver injury, Milos Mihajlovic and his colleagues are developing an advanced human liver model in a dish to better understand how food injection leads to liver damage.